Status:

RECRUITING

Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis

Lead Sponsor:

Amsterdam UMC, location VUmc

Collaborating Sponsors:

Universiteit Leiden

Personal Fitness Nederland

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-67 years

Phase:

NA

Brief Summary

The goal of this randomized controlled trial is to compare the effectiveness of two innovative interventions aimed at preventing cognitive decline and work-related problems to enhanced usual care in i...

Detailed Description

Background Up to 65% of the people with multiple sclerosis (PwMS) develop cognitive deficits that severely affect daily life functioning and PwMS' quality of life. Moreover, approximately 65% of all p...

Eligibility Criteria

Inclusion

  • Confirmed MS diagnosis according to the McDonald 2017 criteria
  • Age between 18 and 67
  • No changes in disease modifying therapy prior to inclusion (i.e., no changes in last 3 months) - this criterion only applies at inclusion to ensure participants are in a stable situation at the start of the study and for follow-up measures, changes in treatment will be registered but will not result in exclusion from the study
  • no current relapse or steroid treatment in the six weeks prior to study visits
  • presence of mild cognitive deficits (at least one test with a Z-score of -1.0 to -1.99 below norm scores of healthy controls on the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery
  • being able to participate in an exercise intervention (i.e., EDSS \< 6.0)
  • fulfilling safety criteria for MRI (no metal inside body, not pregnant, no claustrophobia)

Exclusion

  • presence of neurological (other than MS) and psychiatric disorders
  • a current or history of drug or alcohol abuse
  • being unable to speak or read Dutch
  • currently on sick leave for a period of 6 weeks or longer
  • currently pregnant

Key Trial Info

Start Date :

April 16 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

270 Patients enrolled

Trial Details

Trial ID

NCT06068582

Start Date

April 16 2023

End Date

September 1 2026

Last Update

April 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Amsterdam University Medical Centers, location VUmc

Amsterdam, Netherlands